Clinical trial
Monitoring of the Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor: Study of the Pulmonary and Gut Microbiota and Inflammation
NCT05937815 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Monitoring of the Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor: Study of the Pulmonary and Gut Microbiota and Inflammation
- Lead sponsor
- University Hospital, Bordeaux
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 13, 2021
- Completion date
- September 13, 2026
- Enrollment
- 253 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.